Document:

Sunesis Pharmaceuticals, Inc. 2009 Bonus Program

 Exhibit 10.63 
 SUNESIS PHARMACEUTICALS, INC. 
 2009 BONUS PROGRAM 
 Overview 
 The 2009 Bonus Program (the
“Program”) of Sunesis Pharmaceuticals, Inc. (the “Company”) was adopted effective May 8, 2009 (the “Effective Date”). The Program is designed to motivate, retain and reward
Company employees through a combination of corporate and individual performance-based incentive compensation components during the period commencing on the Effective Date and ending on March 31, 2010 (the “Performance
Period”). Individuals employed by the Company during the Performance Period who are designated for participation by the Compensation Committee of the Company’s Board of Directors (the “Committee”) and who
remain employed by the Company through the Payment Date (as defined below) (each a “Participant”) shall be eligible to earn a bonus under the Program. The Program is administered by the Committee, and any decisions made in
good faith by the Committee shall be final and binding on all Participants and interested parties. 
 The Program is designed to award a cash bonus payment
(each a “Cash Bonus”) for performance during the Performance Period to Participants based in part on the level of achievement (1) by the Company of certain Company-wide objectives (the “Corporate
Objectives”) and (2) by the Participant of certain individual performance objectives, which may include certain department, group and/or team objectives applicable to such Participant (the “Individual
Objectives”). The Committee may require that certain objectives be achieved prior to the end of the Performance Period (e.g., such as achievement not later than December 31, 2009) in order to be eligible to qualify for payment of
the Cash Bonus. 
 Program Objectives 
 The Program is
intended to encourage and reward the following: 
  

	 	•	 	 the achievement of Corporate Objectives, 

  

	 	•	 	 the achievement of Individual Objectives, 

 as well
as to recognize individual contributions and effort. 
 Determination of Program Objectives 
 The Corporate Objectives shall be approved by the Board of Directors, with input from the Committee, management, and generally relate to the achievement of certain
research, clinical development, business development, financial, business and similar milestones. Each Corporate Objective is assigned a relative weighting from the Board of Directors, reflecting its importance to the achievement of the
Company’s key results during the Performance Period; provided, however, the Board of Directors or the Committee may adjust the weighting of the Corporate Objectives in its sole discretion at any time. 
 In addition, the Committee has selected, as a threshold Corporate Objective, the closing of a financing or corporate transaction that provides at least $20 million of
net proceeds (a “Qualifying Transaction”) on or before March 31, 2010. If a Qualifying Transaction does not occur prior to the conclusion of the Performance Period, no Cash Bonuses will be earned under the Program.

 The Individual Objectives shall be set as follows: 
  

	 	•	 	 For the Chief Executive Officer, the Individual Objectives shall be set by the Committee; 

  

	 	•	 	 For Participants who are executive officers (as that term is defined under Section 16 of the Securities Exchange Act of 1934, as amended, and Rule 16a-1
thereunder), other than the Chief Executive Officer (collectively, the “Executive Participants”), the Individual Objectives shall be set by the Committee based upon recommendations made by the Chief Executive Officer;
and 

  

	 	•	 	 For non-Executive Participants (collectively, the “Non-Executive Participants”), the Individual Objectives shall be set by each
Participant’s immediate supervisor, with input from team leaders, group and department heads and others, as appropriate. 

 Program
Bonus Targets 
 Under the Program, each Participant is eligible to earn a cash bonus in an amount up to a specified percentage of his or her annual base
salary that is earned in 2009, with such percentage based [in part] upon the position such Participant holds with the Company (the “Bonus Target”). Under the Program, the Bonus Targets range from 25% to 40% of a
Participant’s 2009 base salary for Vice President level employees and above and from 6% to 20% of a Participant’s 2009 base salary for other Participants. 
 Determination of Cash Bonus Payments 
 The Company will determine the achievement of Corporate Objectives and
Individual Objectives shortly after the end of the Performance Period, as follows: 
 Determination of Level of Achievement of Corporate Objectives 

 The Committee shall determine, after receiving and considering analysis and recommendations from management, the degree to which the Corporate Objectives
have been met, expressed as a percentage of Corporate Objectives achieved, taking into consideration the weighting assigned to each Corporate Objective. Based on the percentage of Corporate Objectives achieved, the Committee will then determine the
final aggregate bonus pool under the Program for all Participants (the “Bonus Pool”). 
 Adjustment of Bonus Targets based on
Level of Achievement of Corporate Objectives 
 Bonus Target levels for Participants will be adjusted based on level of achievement of
Corporate Objectives as determined by the Committee. For example, if the Committee determines that only 80% of the Program’s Corporate Objectives are achieved, each Participant’s Bonus Target will be decreased by 20% (in other words, a
Participant with a 10% Bonus Target will have that Bonus Target reduced to 8%, or 80% of 10%.) Such adjusted Bonus Targets are referred to as the “Adjusted Bonus Targets.” 
 Determination of Bonus Payments for Individual Participants 
 The
actual Cash Bonus earned by a Participant is based on the Participant’s (i) level of contribution to the achievement of the Corporate Objectives; (ii) level of achievement by the Participant against his or her Individual Objectives
and (iii) Adjusted Bonus Target (or, if the Bonus Target was not adjusted, the original Bonus Target). There is no set formula for determining the amount of Cash Bonus earned based on the achievement of Individual Objectives or Corporate
Objectives. Rather, the Committee shall exercise its discretion in determining the amount of Cash Bonus actually earned, which determination will be final and binding. In making its determination, the Committee shall consider the following:

  

	 	•	 	 For the Chief Executive Officer, the Committee’s own evaluation of his achievements; 

	 	•	 	 For Executive Participants, the recommendations made by the Chief Executive Officer; and 

  

	 	•	 	 For Non-Executive Participants, the recommendations made by members of the Executive Committee with input from team leaders, group and department heads and
supervisors, as appropriate. 

 In determining the actual Cash Bonus earned, the Committee may also take into account the achievement of
publicly announced targets, clinical milestones, strategic goals, cross-functional teamwork and collaboration, and unforeseen changes in the economy and/or geopolitical climate. 
 Timing of Cash Payments Under the Program 
 Payment of Cash Bonuses under the Program is expected to occur in the
first quarter following the conclusion of the Performance Period, on such date as determined by the Committee in its sole discretion (the “Payment Date”). A Participant must remain employed by the Company through the Payment
Date in order to earn any Cash Bonus. In no event will the Payment Date occur after March 15, 2011, as the Program is intended to comply with Treasury Regulation Section 1.409A-1(b)(4) and will be interpreted and administered in compliance
therewith to the greatest extent possible. 
 Miscellaneous Provisions 
 Participation in the Program shall not alter in any way the at will nature of the Company’s employment of a Participant, and such employment may be terminated at any time for any reason, with or without cause and
with or without prior notice. Nothing in this Program shall be construed to be a guarantee that any Participant will receive all or part of a Cash Bonus or to imply a contract between the Company and any Participant.
 This Program supersedes and replaces all prior cash incentive and bonus plans of the Company, other than the Change of Control Payment Plan and severance plans (both
Executive and Non-Executive). The Committee may amend or terminate this Program at any time, with or without notice. The Committee may likewise terminate an individual’s participation in the Program at any time, with or without notice.
Further, the Board of Directors or Committee may modify the Corporate Objectives, the Individual Objectives, the Bonus Targets and/or the weighting of the Corporate Objectives at any time. 
 The Program shall be interpreted in accordance with California law without reference to conflicts of law principles.Medical benefits arrangement with James W. Young, Ph.D.

 Exhibit 10.65 
 Medical benefits arrangement with James W. Young, Ph.D. 
 In connection with the 2009 restructuring, James W. Young, Ph.D.
retired as Executive Chairman, effective as of April 3, 2009. In connection with his resignation as Executive Chairman, the Company agreed to cover Dr. Young’s medical benefits for a period of twelve months.fs1a4ex10xi_soact.htm

     

    Exhibit
10.11

     

    SO
ACT NETWORK, INC.

    INDEPENDENT
CONTRACTOR AGREEMENT WITH MATT WELLS

    

    This
Agreement is made on January 19, 2009 between So Act Network, Inc. (“So Act”)
and Matt Wells.

    

    Subject
to the terms and conditions as set forth herein, So Act retains Matt Wells and
Matt Wells hereby accepts So Act's retention to perform services described
herein.

    

    Contractor
Obligations:

    

    In return
for the compensation noted under "Contractor Compensation," contractor
voluntarily agrees to perform services for So Act in designing and implementing
So Act’s website and search engine.

    

    Contractor
Compensation

    

    In full
consideration of all services performed by contractor as described in this
contract, So Act shall issue 80,000 shares of common stock (at an issue price of
$0.0625 per share) for completion of the assigned tasks. Contractor shall be
exclusively responsible for the payment of all taxes incidental to the
compensation paid for services performed, including but not limited to federal
and state income, sales, or use taxation.

    

    Independent
Contractor

    

    Contractor's
relationship to So Act is one of independent contractor. Nothing in the
agreement shall create an employment or agency relationship, nor shall
contractor act as an agent or employee of So Act unless such representation is
outlined in the scope of services.

    

    Contractor's
services are to be performed solely by contractor, or approved subcontractors,
for So Act pursuant to the terms of this contract.

    

    Standards
of Performance

    

    Compliance
with law

    

    Contractor's
performance of services under this agreement shall be in compliance with all
applicable laws or regulations of the federal, state, and local
government.

    

    Reputation
and goodwill

    

    Contractor
shall not perform any contracted services in a manner which would be injurious
to the reputation and goodwill of So Act.

    

    Trade
secrets

    

    Contractor
shall not in any manner disclose to any person, partnership, firm or corporation
any information concerning any matters affecting or relating to the business of
So Act including, but not limited to, any trade secrets, production processes,
customers, pricing or marketing plans. This covenant shall remain in effect
following termination of this contract.

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

     

    Waiver of
liability

    

    So Act
shall not be liable to contractor on account of any personal injuries or
property damage sustained by contractor in performance of services hereunder.
Contractor shall indemnify and hold So Act harmless from all liability for
personal injuries or property damage directly related to the performance of
contracted services.

    

    Modification
of contract

    

    No waiver
or modification of this contract or of any covenant, condition or limitation
herein shall be valid unless presented in writing and signed by both
parties.

    

    Severability

    

    All
covenants contained herein are severable, and in the event of any being held
invalid by any competent court, this contract shall remain intact except for the
omission of the invalid covenant.

    

    Choice of
law

    

    It is the
intention of both parties that all suits that may be brought arising out of, or
in connection with this agreement will be construed in accordance with and under
and pursuant to the laws of the state of Nevada.

    

    Entire
agreement

    

    This
contract contains the complete agreement concerning the services to be performed
by the contractor for So Act and supersedes all prior agreements or
understandings, written or unwritten. By signing this contract, both parties
acknowledge that they have read this contract, understood its terms, including
the release, have had an opportunity to have legal counsel review this
agreement, and have voluntarily accepted its provisions.

    

    Executed
this 19th day of
January, 2009.

     

     

    
      	
              /s/
      Greg
      Halpern                        
      

            	
              /s/
      Matt
      Well                                
      

            
	
              So
      Act Network, Inc.

              Greg
      Halpern, CEO

            	
              Matt
      Wells

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]